Bruker) allows us to search in situ for compounds with anticancer, anti stroke and anti ischemia activity, inhibitors of angiogenesis and hepatoprotective substances. with the Breaking Science News ...

Three partial responses (PR) and one stable disease (SD) out of four evaluable patients with Cutaneous T-cell Lymphoma (CTCL) have been observed in the single agent part of the Phase 2a study. Three ...

ESMO Poster Presentation Highlights ... Inc., is a clinical-stage company relentlessly focused on the discovery and development of precisely designed cancer therapeutics, to transform what science can ...

BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, announces the ...

H.C. Wainwright 26th Annual Global Investment Conference, taking place September 9–11, 2024 in New York, NY Kronos Bio President and Chief Executive Officer, Norbert Bischofberger, Ph.D., will present ...

Rice Unviersity's Global Paris Center will host the Art and Science of Total Synthesis of Natural and ... structure and function in remarkable ways,” Nicolaou said. “From drug discovery to ...

Two abstracts win the prestigious AHA 2024 Paul Dudley White International Scholar Award Allschwil, Switzerland – September 5 ...

Two abstracts win the prestigious AHA 2024 Paul Dudley White International Scholar Award Allschwil, Switzerland - September 5, 2024Idorsia Ltd (SIX: IDIA) today announced that new data on aprocitentan ...

GlyTherix Ltd (GlyTherix) an Australian targeted radiotherapy company specializing in developing antibody ...

India can emerge as the global leader in harnessing AI to power socio-economic development in its centenary of independence ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

A new therapeutic agent discovered and developed at The Ohio State University will soon be used for cancer treatment at the ...